Cargando…

Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data

The integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jinghang, Chen, Zhongyuan, Wang, Honghong, Wang, Yifu, Zheng, Jie, Guo, Yi, Jiang, Yonghua, Mo, Zengnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136255/
https://www.ncbi.nlm.nih.gov/pubmed/37189432
http://dx.doi.org/10.3390/biom13040685
_version_ 1785032174143012864
author Jiang, Jinghang
Chen, Zhongyuan
Wang, Honghong
Wang, Yifu
Zheng, Jie
Guo, Yi
Jiang, Yonghua
Mo, Zengnan
author_facet Jiang, Jinghang
Chen, Zhongyuan
Wang, Honghong
Wang, Yifu
Zheng, Jie
Guo, Yi
Jiang, Yonghua
Mo, Zengnan
author_sort Jiang, Jinghang
collection PubMed
description The integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related proteins and develop a new protein prognostic signature for patients with ovarian cancer to predict their prognosis. Patients were brought together in subgroups using a consensus clustering analysis of prognostic-related proteins. To further investigate the role of proteins and protein-coding genes in ovarian cancer, additional analyses were performed using multiple online databases (HPA, Sangerbox, TIMER, cBioPortal, TISCH, and CancerSEA). The final resulting prognosis factors consisted of seven protective factors (P38MAPK, RAB11, FOXO3A, AR, BETACATENIN, Sox2, and IGFRb) and two risk factors (AKT_pS473 and ERCC5), which can be used to construct a prognosis-related protein model. A significant difference in overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI) curves were found in the training, testing, and whole sets when analyzing the protein-based risk score (p < 0.05). We also illustrated a wide range of functions, immune checkpoints, and tumor-infiltrating immune cells in prognosis-related protein signatures. Additionally, the protein-coding genes were significantly correlated with each other. EMTAB8107 and GSE154600 single-cell data revealed that the genes were highly expressed. Furthermore, the genes were related to tumor functional states (angiogenesis, invasion, and quiescence). We reported and validated a survivability prediction model for ovarian cancer based on prognostic-related protein signatures. A strong correlation was found between the signatures, tumor-infiltrating immune cells, and immune checkpoints. The protein-coding genes were highly expressed in single-cell RNA and bulk RNA sequencing, correlating with both each other and tumor functional states.
format Online
Article
Text
id pubmed-10136255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101362552023-04-28 Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data Jiang, Jinghang Chen, Zhongyuan Wang, Honghong Wang, Yifu Zheng, Jie Guo, Yi Jiang, Yonghua Mo, Zengnan Biomolecules Article The integration of transcriptome and proteome analysis can lead to the discovery of a myriad of biological insights into ovarian cancer. Proteome, clinical, and transcriptome data about ovarian cancer were downloaded from TCGA’s database. A LASSO–Cox regression was used to uncover prognostic-related proteins and develop a new protein prognostic signature for patients with ovarian cancer to predict their prognosis. Patients were brought together in subgroups using a consensus clustering analysis of prognostic-related proteins. To further investigate the role of proteins and protein-coding genes in ovarian cancer, additional analyses were performed using multiple online databases (HPA, Sangerbox, TIMER, cBioPortal, TISCH, and CancerSEA). The final resulting prognosis factors consisted of seven protective factors (P38MAPK, RAB11, FOXO3A, AR, BETACATENIN, Sox2, and IGFRb) and two risk factors (AKT_pS473 and ERCC5), which can be used to construct a prognosis-related protein model. A significant difference in overall survival (OS), disease-free interval (DFI), disease-specific survival (DSS), and progression-free interval (PFI) curves were found in the training, testing, and whole sets when analyzing the protein-based risk score (p < 0.05). We also illustrated a wide range of functions, immune checkpoints, and tumor-infiltrating immune cells in prognosis-related protein signatures. Additionally, the protein-coding genes were significantly correlated with each other. EMTAB8107 and GSE154600 single-cell data revealed that the genes were highly expressed. Furthermore, the genes were related to tumor functional states (angiogenesis, invasion, and quiescence). We reported and validated a survivability prediction model for ovarian cancer based on prognostic-related protein signatures. A strong correlation was found between the signatures, tumor-infiltrating immune cells, and immune checkpoints. The protein-coding genes were highly expressed in single-cell RNA and bulk RNA sequencing, correlating with both each other and tumor functional states. MDPI 2023-04-18 /pmc/articles/PMC10136255/ /pubmed/37189432 http://dx.doi.org/10.3390/biom13040685 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jiang, Jinghang
Chen, Zhongyuan
Wang, Honghong
Wang, Yifu
Zheng, Jie
Guo, Yi
Jiang, Yonghua
Mo, Zengnan
Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_full Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_fullStr Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_full_unstemmed Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_short Screening and Identification of a Prognostic Model of Ovarian Cancer by Combination of Transcriptomic and Proteomic Data
title_sort screening and identification of a prognostic model of ovarian cancer by combination of transcriptomic and proteomic data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136255/
https://www.ncbi.nlm.nih.gov/pubmed/37189432
http://dx.doi.org/10.3390/biom13040685
work_keys_str_mv AT jiangjinghang screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT chenzhongyuan screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT wanghonghong screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT wangyifu screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT zhengjie screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT guoyi screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT jiangyonghua screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata
AT mozengnan screeningandidentificationofaprognosticmodelofovariancancerbycombinationoftranscriptomicandproteomicdata